Abstract
Emerging viral diseases, including seasonal illnesses and pandemics, pose significant global public health risks. Respiratory viruses, particularly coronaviruses and influenza viruses, are associated with high morbidity and mortality, imposing substantial socioeconomic burdens. This review focuses on the current landscape of respiratory viruses, particularly influenza and SARS-CoV-2, and their antiviral treatments. It also discusses the potential for pandemics and the development of new antiviral vaccines and therapies, drawing lessons from past outbreaks to inform future strategies for managing viral threats.
Funding Information
  • Korea Technology and Information Promotion Agency for SMEs (S3302176, HI22C0607)
  • Korea Health Industry Development Institute (KHIDI) (S3302176, HI22C0607)
  • SUNJE Co., Ltd. (SUNJAE-PNU Industry-Academic Cooperation) (S3302176, HI22C0607)

This publication has 256 references indexed in Scilit: